publication date: Apr. 25, 2014
A year before Kapil Mehta’s tenure term expired last August, the 11-member Promotions and Tenure Committee at MD Anderson Cancer Center had unanimously recommended renewal.
“I’ve done everything I’m supposed to do during my tenure,” Mehta said to The Cancer Letter. “I’ve done publications, organized international meetings, service, teaching—everything.”
Mehta’s application was personally rejected by MD Anderson President Ronald DePinho, who overruled the PTC recommendation in May 2012.
Mehta appealed, and a second committee—the Faculty Appeals Panel—endorsed the PTC’s recommendation to renew Mehta’s tenure. However, the administration wasn’t swayed. DePinho’s decision stood.
|Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years|
The Securities and Exchange Commission earlier this week said it has settled insider-trading charges against a prominent cancer researcher who was also an executive of a now-defunct company.
|ASCO Releases Three Guidelines For Survivorship Care|
The American Society of Clinical Oncology published three clinical practice guidelines for the prevention and management of neuropathy, fatigue, depression, and anxiety.
Gareth Morgan named director of UAMS myeloma institute
Michael Gordon named medical director of Virginia G. Piper Cancer Center Clinical Trials
Clinical Research Forum names its Top Ten achievement awards
Conquer Cancer Foundation names 2014 Merit Award winners
Cobas HPV Test approved for primary cervical cancer screening
Arzerra sBLA approved for previously untreated CLL
Cyramza approved for advanced stomach cancer